Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2023 Dec 21;35(1):102108. doi: 10.1016/j.omtn.2023.102108

Retraction Notice to: Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes

Jiebin Yang, Yikai Lian, Renzhi Yang, Yifan Lian, Jingtong Wu, Jingjing Liu, Keming Wang ∗∗, Hongzhi Xu
PMCID: PMC10776980  PMID: 38204915

Main text

(Molecular Therapy: Nucleic Acids 19, 1164–1175; March 2020)

This article has been retracted at the request of the editor-in-chief. The corresponding author (H.X.) contacted the editorial office requesting a correction for image duplication between Figures 4J and 7B. Image analysis conducted by the editorial office confirmed the finding of image duplication. The editors reached out to the authors to request the original data. Per journal policy, the editors, at their discretion, may request deposition of any or all original data files for examination by the reviewers and/or editors. As a result of the authors’ failure to provide these data within 30 days—in violation of journal policy—the editors feel that the findings of the manuscript cannot be relied upon. The co-corresponding author (K.W.) responded agreeing to this retraction.

Contributor Information

Keming Wang, Email: kemingwang@njmu.edu.cn.

Hongzhi Xu, Email: xuhongzhi@xmu.edu.cn.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES